Literature DB >> 11726923

Mutation of the ST7 tumor suppressor gene on 7q31.1 is rare in breast, ovarian and colorectal cancers.

N A Thomas1, D Y Choong, V J Jokubaitis, P J Neville, I G Campbell.   

Abstract

The gene ST7 has recently been implicated as the broad-range tumor suppressor on human chromosome 7q31.1. We did not detect somatic mutations in ST7 in any of 149 primary ovarian, breast or colon carcinomas. These data suggest that epigenetic downregulation or haploinsufficiency, rather than somatic genetic alterations, may be the primary mechanism of abrogation of ST7 function in these tumor types.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11726923     DOI: 10.1038/ng784

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  5 in total

1.  Localization and characterization of ST7 in cancer.

Authors:  Nurdina Charong; Pimpicha Patmasiriwat; Jean Claude Zenklusen
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-18       Impact factor: 4.553

2.  Somatic mutation analysis of p53 and ST7 tumor suppressor genes in gastric carcinoma by DHPLC.

Authors:  Chong Lu; Hui-Mian Xu; Qun Ren; Yang Ao; Zhen-Ning Wang; Xue Ao; Li Jiang; Yang Luo; Xue Zhang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

3.  Mutations in the ST7/RAY1/HELG locus rarely occur in primary colorectal, gastric, and hepatocellular carcinomas.

Authors:  S Yoshimura; T Yamada; S Ohwada; T Koyama; K Hamada; K Tago; I Sakamoto; I Takeyoshi; T Ikeya; F Makita; Y Iino; Y Morishita
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

4.  Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemia.

Authors:  Robert J Weeks; Ursula R Kees; Sarah Song; Ian M Morison
Journal:  Mol Cancer       Date:  2010-06-24       Impact factor: 27.401

5.  Lack of mutations within ST7 gene in tumour-derived cell lines and primary epithelial tumours.

Authors:  V L Brown; C M Proby; D M Barnes; D P Kelsell
Journal:  Br J Cancer       Date:  2002-07-15       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.